In a stunning ruling this week, US District Court Judge Roger Titus ruled from the bench in Greenbelt, Maryland, granting a Motion for a Judgment of Acquittal filed by the defendant, Lauren Stevens, who was formerly an in-house lawyer for UK drugs giant GlaxoSmithKline (LSE: GSK), writes John Fleder of Hyman, Phelps & McNamara on the law firm’s FDA aw Blog.
Earlier this year, federal US prosecutors in the criminal case against Ms Stevens received a double dose of bad news. First, the judge ruled against the government in saying that Ms Stevens can claim an advice-of-counsel defense to the charges against her. Then the judge dismissed the case without prejudice (The Pharma Letter March 28).
On May 10, Judge Titus stated that this was the first case in his seven and a half years as a jurist when he has granted such a motion. Because jeopardy had already attached, this ruling is not appealable by the government and ends this criminal case against her.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze